What is Lidocaine/Lignocaine 5% Ointment Xylocaine®
Lidocaine 5% topical is used to temporarily numb and relieve pain from minor burns (including sunburn), skin abrasions, insect bites, and other painful conditions affecting mucous membranes. Lidocaine belongs to a class of drugs called local anesthetics.
Xylocaine® Ointment is used as a topical local anesthetic to provide analgesia (pain relief) to a local area of skin for certain minor surgical procedure. These include needle insertion, such as taking blood samples or applying intravenous catheters; cleaning leg ulcers; superficial surgical procedures like split skin grafting and superficial surgery involving genital skin. When applied to the skin prior to the procedure, Xylocaine® Ointment provides effective analgesia throughout the procedure, which continues for some time after.
Xylocaine® Ointment contains an anaesthetic lignocaine 5%. This anesthetic is amino amide that acts directly on nerve endings in the skin to block the generation and transmission of specific nerve impulses in a defined area, and this provides reversible loss of sensation in the superficial pain receptors. Lignocaine work by stabilising the membranes of nerve cells by blocking the influx of sodium ions through voltage-gated sodium channels in the cell membranes and this inhibits the generation of a nerve impulse and its transmission to the brain, which means that no sensation of pain will be received by the pain receptors, although other sensations such as pressure may still be perceived. Xylocaine® Ointment is absorbed through the layers of the skin reaching the nerve endings and pain receptors, where they work together to numb the area of skin before a potentially painful procedure such an injection.
Brand Names: AneCream, Bactine, Glydo, LidaMantle, Lidoderm, LidoRx, Medi-Quik Spray, RadiaGuard, Regenecare HA Spray, Solarcaine Aloe Extra Burn Relief
Cadila Pharmaceuticals is a multinational research-based pharmaceutical group in India with more than 5 decades of experience. Company's integrated operations cover the entire gamut from manufacturing products ranging from API's-Intermediates, finished formulations, OTC-Food Supplements, Biotechnology Products, and Pharmaceutical Machinery. Cadila Pharmaceuticals manufacturing facilities are approved by most stringent International bodies like WHO-GMP, UK-MHRA, USFDA-API, TGA-Australia, and AIFA-Italy. International operation of Cadila Pharmaceuticals is spread across 58 countries including the Americas, Japan, Asia, CIS, and Africa. Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over the past six decades, we have been developing and manufacturing affordable medicines for patients around the world. Our innovation-led drug discovery processes ensure the health and well-being of people around the world. Our enhanced investment in innovation and a strong track record in research and development have produced medical miracles that have changed lives and made a profound impact on real life. Being a care-focused, research-driven company, we are committed to complying with the highest ethical standard in clinical research and medical practice. We want to be valued not only for our pharmaceutical products but also for the way we conduct our research and business activities. We lead our industry in demonstrating the application of cutting-edge research to ethical business practices in producing the alchemy of optimum health outcomes for all. Our vision is to be a leading pharmaceutical company in India and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment. We will discover, develop and successfully market pharmaceutical products to prevent, diagnose, alleviate and cure diseases. We shall provide total customer satisfaction and achieve leadership in chosen markets, products and services across the globe, through excellence in technology, based on world-class research and development. We are responsible to society. We shall be good corporate citizens and will be driven by high ethical standards in our practices.